RXElite Stock

RXElite P/S

(Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of RXElite (RXEI) as of Aug 5, 2026.

P/S

0.00

Last updated:

As of Aug 5, 2026, RXElite's P/S ratio stood at 0.00, a % change from the - P/S ratio recorded in the previous year.

The RXElite P/S history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/S
Date
P/S
Jan 1, 2005
0.00 base
Jan 1, 2006
0.00 base
Jan 1, 2007
0.00 base
YEARP/S
2007 -
2006 -
2005 -
Access this data via the Eulerpool API

RXElite Stock analysis

What does RXElite do? RXElite Inc is a US-based company operating in the pharmaceutical and biotechnology sector. The company was founded in 1999 and is headquartered in Phoenix, Arizona. RXElite Inc specializes in the manufacturing and marketing of innovative medications and therapies developed and produced for both the American and international markets. RXElite Inc has various divisions and business sectors that focus on different demand patterns within the pharmaceutical and biotech industry. One area in which the company operates is the manufacturing of prescription medications, including prescription pain relievers and medications for inflammation and other diseases. Furthermore, RXElite Inc is involved in the development and manufacturing of generic drugs, which have the same active ingredient composition as existing brand-name medications. Generics are typically more affordable than brand-name medications and can result in cost savings for patients. Another business segment of RXElite Inc is the production of dietary supplements and vitamin preparations. The company uses natural ingredients and emphasizes high quality to meet the increasing demands of customers. RXElite Inc also operates in the field of medical device development and marketing, aiming to improve the diagnosis and treatment of diseases. This includes devices for measuring blood pressure or blood sugar levels, as well as ventilators. The RXElite Inc business model is diversified, aiming to meet existing market needs and explore new market segments. The company combines research, development, and production to provide customers with innovative and high-quality products. In recent years, RXElite Inc has expanded its portfolio and strengthened its position in the pharmaceutical and biotech sector through various acquisitions and partnerships. One important acquisition was the takeover of American Wholesale Distributors in 2006, which provided RXElite Inc with access to a broader customer base and new markets. International expansion is another focus of RXElite Inc. The company has opened several branches in Asia, Europe, and Latin America to increase its market share and expand its global presence. RXElite Inc places great emphasis on innovation and research and development. The company continuously invests in the exploration of new active ingredients and manufacturing processes for medications. RXElite Inc also has strong partnerships with various universities and research institutions to strengthen collaboration and promote the exchange of ideas and expertise. Overall, RXElite Inc is a dynamic and diversified company that occupies a leading position in the pharmaceutical and biotech sector due to its comprehensive portfolio of products and services, as well as its global reach. RXElite Inc strives to meet the needs of its customers and strengthen its position in the market through continuous innovation and expansion. RXElite is one of the most popular companies on Eulerpool.

P/S Details

Decoding RXElite's P/S Ratio

RXElite's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing RXElite's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating RXElite's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in RXElite’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about RXElite stock

On Eulerpool you can find the complete historical development of (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. RXElite since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Sales Ratio (P/S Ratio) is a financial metric that represents the ratio between the current price of a stock and the sales per share of the company. It is commonly used to assess the valuation of a stock compared to other stocks in the same industry or compared to the overall average of the stock market.

P/S Formula:
P/S = Price of a stock / Sales of a stock
If you can't find the Sales per Share (SPS) right away, which is the equivalent term for Revenue per Share in English, you can also calculate this value by dividing the company's total sales by the number of issued shares.

SPS Formula:
Total sales of the company / Number of issued shares
The Sales per Share or Revenue per Share can usually be easily found on most financial websites.

The P/S ratio is often used to assess the valuation of a stock compared to other stocks in the same industry or the overall stock market average. It can provide insights into how well the company is performing in terms of revenue per share compared to its competitors. A low P/S ratio may indicate that the company is generating relatively high revenue per share compared to other companies in the industry, which can be positive. On the other hand, a high P/S ratio may indicate that the company is generating relatively low revenue per share compared to its competitors, which can be negative.

To evaluate (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company.'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company..

A 'good' varies by industry and company stage. On Eulerpool, you can compare (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company.'s RXElite with sector peers and the industry average to assess whether it is attractive.

The P/S ratio when valuing a stock.

The price-to-sales ratio (P/S ratio) is an important tool of technical analysis that assists investors in evaluating stocks. It refers to the earnings per share of a company and its price movements. This indicator can be used to determine a stock's fair value, relative to the company's earnings.

History of the Price-to-Sales Ratio

The price-to-sales ratio is a relatively new indicator. It was first used in the 1980s by John Price when he developed the Price-to-Sales Index (PSI). Price wanted to find a way to value stocks taking into account their earnings. He noticed that many stock prices were not in line with their earnings situation. The PSI has since become an important analytical tool and is often referred to as the P/S ratio.

Calculation of the price-to-sales ratio

The price-to-sales ratio is easy to calculate. It is determined by dividing the current stock price by the company's earnings per share. P/S ratio = Stock price / Earnings per share. For example, if a company's stock price is $10 and the earnings per share is $2, then the P/S ratio is 5.

Application of the Price-to-Sales Ratio

The Price-to-Sales ratio is a useful tool for determining a fairly valued stock price. A low P/S ratio may indicate that a stock price is undervalued, which could be a good entry opportunity. However, a high Price-to-Sales ratio may indicate that a stock price is overvalued and investors should exercise caution.

An example: A company has a stock price of 20 USD and an earnings per share of 2 USD. The P/E ratio is 10. This could indicate that the stock price is overvalued and investors should be cautious before buying.

Investors and the price-to-sales ratio

Investors use the price-to-sales ratio to determine whether a company's stock price is fairly valued or not. They can compare the P/S ratio to see how the stock price relates to the company's earnings. Investors can also observe the P/S ratio over a longer period of time to see if the stock price changes in relation to the company's earnings.

Advantages and Disadvantages of the Price-to-Sales Ratio

The greatest advantage of the price-to-sales ratio is that it is a simple and understandable tool to determine the fair value of a stock price. It can also help investors identify stocks that are undervalued. One disadvantage is that the P/S ratio does not provide information about the company's profits. Therefore, investors should also consider other financial ratios before investing.

In today's time, the price-to-sales ratio is an important tool for investors to evaluate stocks and identify potential investment opportunities. It can help find a fairly valued stock price and identify stocks that are undervalued. However, investors should also consider other financial indicators before making an investment decision.

Access this data via the Eulerpool API

Valuation — RXElite

All Key Metrics — RXElite